ClinicalTrials.Veeva

Menu

Effects of High-Flow Nasal Cannula on Exercise Outcomes in Lung Transplant Candidates: A Pilot Study

H

Hospital Israelita Albert Einstein

Status

Completed

Conditions

Pulmonary Diseases
Oxygen Therapy
High-flow Nasal Cannula
Exercise Tolerance

Treatments

Other: Functional Tests
Other: Performance Tests

Study type

Interventional

Funder types

Other

Identifiers

NCT06620081
26495219.1.0000.0071

Details and patient eligibility

About

The study evaluated patients on the national lung transplant waiting list. It was pioneering in assessing high-complexity patients with severe pulmonary diseases subjected to a cardiopulmonary rehabilitation protocol using a treadmill. The main findings indicate that the distance covered in the six-minute walk test was greater when using the high-flow nasal cannula supplementation. The improvement in exercise performance in this group is associated with a reduction in arterial carbon dioxide, optimization of hydrogen potential, and a decrease in dynamic hyperinflation, leading to fewer symptoms of dyspnea.

Full description

Introduction: Pulmonary diseases have a significant global prevalence, and lung transplantation is indicated for advanced cases. Rehabilitation is essential for patients on the waiting list and requires ventilatory devices for symptom control during exertion. The high-flow nasal cannula is a promising alternative, but its effects on exercise outcomes are uncertain. Objectives: To assess the effects of high-flow nasal cannula on the outcomes of the six-minute walk test. Method: A randomized crossover clinical trial evaluated ten volunteers listed on the national lung transplant waiting list. Three functional tests were performed: the six-minute walk test, incremental lower limb test with arterial blood gas analysis, and lower limb endurance test with inspiratory capacity measurement. Each test was conducted on different days with different devices: high-flow nasal cannula and conventional oxygen therapy, totaling six test days. The inspired oxygen fraction was titrated to maintain normoxia between 90% to 96% and was kept constant for both interfaces.

Enrollment

10 patients

Sex

All

Ages

30 to 69 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Volunteers of both sexes
  • Patients on the national lung transplant waiting list
  • Chronic obstructive pulmonary disease
  • Idiopathic or familial pulmonary fibrosis
  • Bronchiectasis
  • Sarcoidosis

Exclusion criteria

  • Osteoarticular limitation,
  • Neuromuscular disease,
  • Anemia
  • Hyperglycemia
  • Arrhythmia
  • Left heart failure
  • Pulmonary hypertension

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

10 participants in 2 patient groups

Oxygen therapyHigh flow nasal cannula
Experimental group
Description:
High-Flow Nasal Cannula Therapy (HFNC Therapy).
Treatment:
Other: Performance Tests
Other: Functional Tests
Conventional oxygen therapy
Active Comparator group
Description:
Conventional Oxygen Therapy with Venturi Mask or Non-Rebreather Mask.
Treatment:
Other: Performance Tests
Other: Functional Tests

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems